Last updated on November 2017

KOWA Hypertriglyceridemia 303


Brief description of study

KOWA Hypertriglyceridemia 303

Detailed Study Description

A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels =500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment

Clinical Study Identifier: TX8387

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Research Center

Columbus Regional Research Institute
Columbus, GA USA
  Connect »